Back to Insider Trading View Full Company Profile

CABA

HEALTHY

Cabaletta Bio, Inc.

CIK: 0001759138

Buy (70% confidence)

Last activity: 3 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Net Income -$115.86M
Total Cash $122.22M

Trend Signals

CEO Buy STRONG

CEO buying activity

3 weeks ago

Insider Roster (8 total, 8 active)

Insider Buys Sells Net Value Holdings
Nichtberger Steven
President & CEO
1 0 $101K
1,031,483 shares
$2.31M
Tomasello Shawn
OTHER
1 0 $50K
22,725 shares
$50K
Gavel Steve
Chief Commercial Officer
1 0 $50K
22,170 shares
$50K
Simon Mark
OTHER
1 0 $25K
147,205 shares
$336K
Binder Gwendolyn
President, Science & Tech.
1 0 $25K
31,312 shares
$69K
Chang David J.
Chief Medical Officer
1 0 $20K
8,800 shares
$20K
Gerard Michael
General Counsel
1 0 $15K
6,600 shares
$15K
Bollard Catherine
OTHER
1 0 $10K
5,405 shares
$12K

Recent Transactions

BUY Nichtberger Steven (President & CEO)

45,000 shares @ $2.24

$101K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Tomasello Shawn (OTHER)

22,725 shares @ $2.21

$50K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Gavel Steve (Chief Commercial Officer)

22,170 shares @ $2.27

$50K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Simon Mark (OTHER)

11,061 shares @ $2.28

$25K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Binder Gwendolyn (President, Science & Tech.)

11,312 shares @ $2.19

$25K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Chang David J. (Chief Medical Officer)

8,800 shares @ $2.26

$20K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Gerard Michael (General Counsel)

6,600 shares @ $2.27

$15K

Jan 21, 2026

Conviction: | View SEC Filing →
BUY Bollard Catherine (OTHER)

4,405 shares @ $2.27

$10K

Jan 21, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.